NVE Corp Files 8-K Amendment
Ticker: NVEC · Form: 8-K/A · Filed: Feb 13, 2025 · CIK: 724910
| Field | Detail |
|---|---|
| Company | Nve CORP /New/ (NVEC) |
| Form Type | 8-K/A |
| Filed Date | Feb 13, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, material-agreement
Related Tickers: NVEE
TL;DR
NVE Corp filed an 8-K amendment for a Jan 1, 2006 agreement.
AI Summary
NVE Corp filed an amendment (Amendment No. 10) to its Form 8-K on February 13, 2025, related to an event that occurred on January 1, 2006. The filing pertains to an entry into a material definitive agreement.
Why It Matters
This filing is an amendment to a previous report, indicating updates or corrections to a material definitive agreement entered into by NVE Corp.
Risk Assessment
Risk Level: low — This is a routine amendment to a historical filing, not indicating new or immediate risks.
Key Numbers
- 000-12196 — SEC File Number (NVE Corp's SEC filing identifier)
- 41-1424202 — IRS Employer Identification No. (NVE Corp's tax identification number)
Key Players & Entities
- NVE Corp (company) — Registrant
- February 13, 2025 (date) — Filing Date
- January 1, 2006 (date) — Earliest Event Reported Date
- 11409 Valley View Road, Eden Prairie, Minnesota 55344 (address) — Principal Executive Offices
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing is an amendment (Amendment No. 10) to a previous report, specifically addressing an entry into a material definitive agreement by NVE Corp.
When was the original event reported that this amendment relates to?
The earliest event reported that this amendment relates to occurred on January 1, 2006.
What is NVE Corp's principal executive office address?
NVE Corp's principal executive office is located at 11409 Valley View Road, Eden Prairie, Minnesota 55344.
What is NVE Corp's fiscal year end?
NVE Corp's fiscal year ends on March 31.
What is the SIC code for NVE Corp?
NVE Corp's Standard Industrial Classification (SIC) code is 3674, Semiconductors & Related Devices.
Filing Stats: 825 words · 3 min read · ~3 pages · Grade level 9 · Accepted 2025-02-13 16:08:51
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value NVEC The NASDAQ Stock Mar
Filing Documents
- nvec-20060101.htm (8-K/A) — 23KB
- nve_ex10z6.htm (EX-10.6) — 12KB
- nve8kz_1.gif (GRAPHIC) — 1KB
- 0001376474-25-000205.txt ( ) — 170KB
- nvec-20060101_def.xml (EX-101.DEF) — 2KB
- nvec-20060101_lab.xml (EX-101.LAB) — 17KB
- nvec-20060101_pre.xml (EX-101.PRE) — 11KB
- nvec-20060101.xsd (EX-101.SCH) — 2KB
- nvec-20060101_htm.xml (XML) — 3KB
01. Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement. General Information We supply products to Abbott under the Supplier Partnering Agreement as amended. Description of the Terms and Conditions of the Amendment On February 10, 2025, Amendment No. 11 to the Supplier Partnering Agreement was executed, extending the Agreement term through December 31, 2025 and increases pricing for 2025. The Amendment is filed as Exhibit 10.6 to this Current Report on Form 8-K/A. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date February 13, 2025 NVE CORPORATION (Registrant) /s/ DANIEL A. BAKER Daniel A. Baker President & Chief Executive Officer 3 INDEX TO EXHIBITS Exhibit # Description 10.1 Indemnification Agreement by and between Pacesetter, Inc., a St. Jude Medical Company, d.b.a. St. Jude Medical Cardiac Rhythm Management Division, and the company (incorporated by reference to the Form 8-K filed September 27, 2005). 10.2+ Supplier Partnering Agreement by and between St. Jude and the company (incorporated by reference to the Form 8-K filed January 4, 2006). 10.3 Amendment No. 4 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed February 7, 2011). 10.4 Amendment No. 5 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed April 21, 2016). 10.5* Amendment No. 8 to Supplier Partnering Agreement between Abbott and the company (incorporated by reference to the Form 8-K/A filed February 2, 2022). 10.6* Amendment No. 11 to Supplier Partnering Agreement between Abbott and the company (filed with this Current Report on Form 8-K/A). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). +Confidential portions of this exhibit were deleted